Thebioavailabilityofsubcutaneousinjectionisabout90%.Theeliminationhalf-lifeafterintravenousinjectionisabout2hours,and3-4hoursaftersubcutaneousinjection.Thehalf-lifeofuremiapatientswillbeextended.Beyon
Thisproductisabloodsuppositorycontainingdextroheparinsodium.Dextroheparinsodiumisalowmolecularweightheparinsodiumderivedfromthemucosaofpigintestineswithanaveragemolecularweightof5000.Dheparinsodiummai
Protaminecaninhibittheanticoagulanteffectofdheparinsodium.Theprolongationofclottingtimeinducedbythisproductcanbecompletelyneutralized,buttheanti-xaactivityisonlymoderatetoabout25-50%.1mgprotaminecanin
Simultaneoususeofagentsthataffecthemostasis,suchasthrombolyticagents,acetylsalicylicacid,nonsteroidalanti-inflammatoryagents,vitaminKantagonists,anddextran,mayenhancetheanticoagulanteffectofheparinsod